Lifecore Biomedical
LFCR
LFCR
95 hedge funds and large institutions have $206M invested in Lifecore Biomedical in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 26 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
1.08% less ownership
Funds ownership: 92.85% → 91.76% (-1.1%)
12% less capital invested
Capital invested by funds: $235M → $206M (-$29.2M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
95
Holding in Top 10
2
Calls
$15K
Puts
$11K
Top Buyers
| 1 | +$4.16M | |
| 2 | +$2.55M | |
| 3 | +$1.8M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$1.4M |
| 5 |
Renaissance Technologies
New York
|
+$659K |
Top Sellers
| 1 | -$2.3M | |
| 2 | -$1.69M | |
| 3 | -$1.5M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$854K |
| 5 |
HFA
Harbert Fund Advisors
Birmingham,
Alabama
|
-$615K |